Skip to content

Clinical study for the effect of prebiotics in patients with breast cancer

Clinical study for the effect of prebiotics in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008348
Enrollment
30
Registered
2023-04-11
Start date
2021-10-27
Completion date
Unknown
Last updated
2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : MD FIT H-BALANCE Oral intake twice a day for 90 days

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? A person who agreed to participate in this study and signed a written consent form ? Among breast cancer patients aged 20 years or older, those who have completed both chemotherapy and radiotherapy after surgery

Exclusion criteria

Exclusion criteria: ? If participated person is diagnosed with the following diseases Liver dysfunction or hepatobiliary disease renal dysfunction Previous history of cancer other than breast cancer ? Those who have taken or administered antibiotics within the last 1 month ? A person who has continuously consumed food (including health functional food) that may affect intestinal health within the past month : Probiotics (lactic acid bacteria, etc.), prebiotics (dietary fiber, fructooligosaccharides, etc.) ? Those who have hypersensitivity to prebiotics or ingredients or have experienced severe food allergic reactions ? Those who have participated in other clinical studies within the last 1 month ? Those who abuse alcohol/drugs or are suspected of abuse ? People unable to communicate ? People with other diseases that the researcher deems inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
Based on the established human microbiome profile, the pattern and rate of change before and after the intake of the test food was investigated based on the markers of beneficial bacteria and harmful bacteria through microbiome analysis

Secondary

MeasureTime frame
the pattern and rate of change before and after the intake of the test food was investigated based on the markers of beneficial bacteria and harmful bacteria through biochemical analysis such as lipid profile tests and liver function tests etc. before and after ingestion of the test food were evaluated.

Countries

Korea, Republic of

Contacts

Public ContactJeongshin An

Ewha Womans University Medical Center

jsan@ewha.ac.kr+82-2-2650-2866

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026